Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam vs. Fentanyl for Cancer Breakthrough Pain in Bone Metastases
NCT02382653Completed
- Sponsor
- Tanta University
- Start
- Dec 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of piroxicam in breakthrough cancer pain (BTcP), sponsored by Tanta University. Primary endpoint: Visual Analog Scale at 30 days. Started Dec 2014; status: completed.
02
Drugs
piroxicam
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT02382653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382653.